BioSpace News Archive

Vivera Pharmaceuticals, Inc., is pleased to announce the expansion of its exclusive global licensing of the novel TABMELT® platform to Russia

With the advantage of remote access and remote monitoring, patients and physicians alike have been exhibiting a growing preference toward telemedicine.

The growing popularity of customized medicine is reshaping the global compounding pharmacies market outlook.

By 2026, the North America cell line development market size is estimated to be around $2.7 billion, triggered by the escalating demand for COVID-19 treatments that involve monoclonal antibodies.

Break Through Cancer (www.breakthroughcancer.org) today announced its formal launch as a public foundation designed to find new solutions to the most intractable challenges in cancer.

Median Technologies (ALMDT:PA) (Paris:ALMDT) announced today the appointment of Thomas Bonnefont to the newly created position of Chief Operating and Commercial Officer of the iBiopsy® Business Unit as well as the appointment of Mike Doherty as Sr. Strategy

Our climate is changing, and those changes impact critical infrastructure in the U.S. Patterns of floods, fires, heatwaves, and hurricanes are shifting, and forward-thinking companies are taking steps to analyze current and future climate-related risks so they can improve the resiliency of their infrastructure and keep critical services up and running.

Harvard University and Kyowa Kirin Co., Ltd. announce that they have entered into a strategic research alliance.

Net revenues of $22.4 million in the fourth quarter and $69.2 million for the full year of 2020, representing 110.8% and 110.9% increases, respectively, over the corresponding periods of 2019

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company and leader in targeted C3 therapies, announced its fourth quarter and full year 2020 financial results and business highlights.